Transgenic bcl-2 is not sufficient to rescue all hematolymphoid defects in STAT5A/5B-deficient mice

Experimental Hematology

Volumn 31, Issue 12, 2003, Pages 1253-1258

  Snow, Jonathan W ^a,b   Abraham, Ninan ^a   Ma, Melissa C ^a   Bronson, Sarah K ^c   Goldsmith, Mark A ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; PROTEIN BCL 2; STAT5A PROTEIN; STAT5B PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLOOD CELL COUNT; BONE MARROW CELL; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOPENIA; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; TRANSGENE; TRANSGENIC MOUSE;

EID: 0345097318     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2003.09.014     Document Type: Article

References (50)

1. Grimley P.M., Dong F., Rui H. Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev. 10:1999;131-157.
2. Bunting K.D., Bradley H.L., Hawley T.S., et al. Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. Blood. 99:2002;479-487.
3. Snow J.W., Abraham N., Ma M.C., et al. STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells. Blood. 99:2002;95-101.
4. Zhang S., Fukuda S., Lee Y., et al. Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling. J Exp Med. 192:2000;719-728.
5. Kieslinger M., Woldman I., Moriggl R., et al. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev. 14:2000;232-244.
6. -/- mice: a direct role for Stat5 in bcl-X(L) induction. Cell. 98:1999;181-191.
7. -/- mice due to decreased survival of early erythroblasts. Blood. 98:2001;3261-3273.
8. Kagami S., Nakajima H., Kumano K., et al. Both stat5a and stat5b are required for antigen-induced eosinophil and T cell recruitment into the tissue. Blood. 95:2000;1370-1377.
9. Kagami S., Nakajima H., Suto A., et al. Stat5a regulates T helper cell differentiation by several distinct mechanisms. Blood. 97:2001;2358-2365.
10. Moriggl R., Sexl V., Piekora R., Topham D., Ihle J.N. Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity. 11:1999;225-230.
11. Moriggl R., Topham D.J., Teglund S., et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity. 10:1999;249-259.
12. Sexl V., Piekorz R., Moriggl R., et al. Stat5a/b contribute to interleukin-7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5. Blood. 96:2000;2277-2283.
13. Teglund S., McKay C., Schuetz E., et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 93:1998;841-850.
14. Van Parijs L., Refaeli Y., Lord J.D., et al. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity. 11:1999;281-288.
15. Battle T.E., Frank D.A. The role of STATs in apoptosis. Curr Mol Med. 2:2002;381-392.
16. O'Shea J.J., Gadian M., Schreiber R.D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 109:(suppl):2002;S121-S131.
17. Shelburne C., McCoy M., Piekorz R., et al. Stat5: an essential regulator of mast cell biology. Mol Immunol. 38:2002;1187-1191.
18. Antonsson B., Martinou J.C. The bcl-2 protein family. Exp Cell Res. 256:2000;50-57.
19. Cory S., Adams J.M. The bcl-2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2:2002;647-656.
20. Gross A., McDonnel J.M., Korsmeyer S.J. bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1999;1899-1911.
21. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., Weissman II. bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell. 89:1997;1033-1041.
22. Lagasse E., Weissman I.L. Enforced expression of bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell. 89:1997;1021-1031.
23. Kondo M., Akashi K., Domen J., Sugamura K., Weissman I.L. bcl-2 rescuss T lymphopoiesis, but not B or NK cell development, in common γ chain-deficient mice. Immunity. 7:1997;155-162.
24. Maraskovsky E., Peschon J.J., McKenna H., Teepe M., Strasser A. Overexpression of bcl-2 does not rescue impaired B lymphopoiesis in IL-7 receptor-deficient mice but can enhance survival of mature B cells. Int Immunol. 10:1998;1367-1375.
25. + T cells and intestinal intraepithelial T cells in IFN-regulatory factor-1-deficient mice. J Immunol. 166:2001;6509-6513.
26. Rodewald H.R., Waskow C., Haller C. Essential requirement for c-kit and common γ chain in thymocyte development cannot be overruled by enforced expression of bcl-2. J Exp Med. 193:2001;1431-1437.
27. Bronson S.K., Plaehn E.G., Kluckman K.D., et al. Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci U S A. 93:1996;9067-9072.
28. Veis D.J., Sorenson C.M., Shutter J.R., Korsmeyer S.J. bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:1993;229-240.
29. Haneline L.S., Gobbett T.A., Ramani R., et al. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood. 94:1999;1-8.
30. Wagers A.J., Christensen J.L., Weissman I.L. Cell fate determination from stem cells. Gene Ther. 9:2002;606-612.
31. Bittorf T., Seiler J., Ludtke B., et al. Activation of STAT5 during EPO-directed suppression of apoptosis. Cell Signal. 12:2000;23-30.
32. Motoyama N., Kimura T., Takahashi T., Watanabe T., Nakano T. bcl-x prevents apoptotic cell death of the both primitive and definitive erythrocytes at the end of maturation. J Exp Med. 189:1999;1691-1698.
33. Wagner K.U., Claudio E., Rucker E.B., et al. Conditional deletion of the bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development. 127:2000;4949-4958.
34. + progenitors but is absent from senescent megakaryocytes. Exp Hematol. 29:2001;728-735.
35. Terui Y., Furukawa Y., Kikuchi J., et al. bcl-x is a regulatory factor of apoptosis and differentiation in megakaryocytic lineage cells. Exp Hematol. 26:1998;236-244.
36. Grillot D.A., Merino R., Pena J.C., et al. bcl-x exhibits regulated expression during B-cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med. 183:1996;381-391.
37. Nakayama K., Negishi I., Kuida K., et al. Disappearance of the lymphoid system in bcl-2 homozygous mutant chimeric mice. Science. 261:1993;1584-1588.
38. Lord J.D., McIntosh B.C., Greenberg P.D., Nelson B.H. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2 and bcl-x genes through the trans-activation domain of Stat5. J Immunol. 164:2001;2533-2541.
39. Zamorano J., Wang H.Y., Wang R., et al. Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression. J Immunol. 160:1998;3502-3512.
40. Domen J. The role of apoptosis in regulating hematopoietic stem cell numbers. Apoptosis. 6:2001;239-252.
41. Domen J., Cheshier S.H., Weissman I.L. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of bcl-2 increases both their number and repopulation potential. J Exp Med. 191:2000;253-264.
42. Domen J., Gandy K.L., Weissman I.L. Systemic overexpression of bcl-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood. 91:1998;2272-2282.
43. Feldman G.M., Rosenthal L.A., Liu X., et al. STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood. 90:1997;1768-1776.
44. Matsumura I., Kitamura T., Wakao H., et al. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18:1999;1367-1377.
45. -/- mice. Cell. 89:1997;1011-1019.
46. Sentman C.L., Shutter J.R., Hockenbery D., Kanagawa O., Korsmeyer S.J. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67:1991;879-888.
47. Chao D.T., Linette G.P., Boise L.H., White L.S., Thompson C.B., Korsmeyer S.J. bcl-XL and bcl-2 repress a common pathway of cell death. J Exp Med. 182:1995;821-828.
48. Mazel S., Burtrum D., Petrie H.T. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med. 183:1996;2219-2226.
49. O'Reilly L.A., Huang D.C., Strasser A. The cell death inhibitor bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15:1996;6979-6990.
50. Ogilvy S., Metcalf D., Print C.G., Bath M.L., Harris A.W., Adams J.M. Constitutive bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci U S A. 96:1999;14943-14948.